Treat-to-Target of Endoscopic Remission in Patients with IBD in Symptomatic Remission

Go Back to All Clinical Trials

Treat-to-Target of Endoscopic Remission in Patients with IBD in Symptomatic Remission

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Ibd
Age: Between 18 Year(s) - 80 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Male or nonpregnant, nonlactating females, aged 18 to 80 years (inclusive).
2. An established diagnosis of Crohn’s disease (CD) or ulcerative colitis (UC) for at least 6 months based on standard clinical criteria.
3. Current treatment with an approved targeted immunomodulator (TIM) for treatment of IBD.
4. Able to participate fully in all aspects of this clinical trial.

You may not be eligible for this study if the following are true:

1. Presence of ostomy or ileonal pouches.
2. History of alcohol or drug abuse.
3. Prior enrollment in the current study.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies